PLAINSBORO, N.J., Feb. 28, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Radionics, Inc., has launched the InterFix(TM) Radiosurgery Kit for use with TomoTherapy(R) radiation treatment systems. The InterFix(TM) Radiosurgery Kit provides a way to adapt the existing Integra Radionics(TM) stereotactic hardware to the TomoTherapy(R) Hi-Art(R) system for stereotactic treatment of cranial tumors and vascular malformations. The InterFix(TM) Radiosurgery Kit has received FDA clearance in the United States, as well as CE Mark Certification in the European Union.
